MD Biosciences expands biomarker-based research services to the Massachusetts region featuring Inflammation and CNS disease models Read More
Life Sciences Contract Research & ManufacturingCambridge, MA
MD Biosciences is a global industry-leading provider of preclinical, translational and clinical-phase contract research services for the development of pharmaceutical and diagnostic assets. With AAALAC-accredited, GLP-compliant, CLIA facilities, we offer expertise, services and products across a wide range of therapeutic areas including inflammatory diseases, autoimmunity, neurology, oncology, metabolism and pain.
Preclinical services include efficacy and mode of action studies in the inflammation, immuno-oncology and CNS therapeutics areas. Translational services featuring porcine models and full-service histology/IHC/ISH capabilities bridge the gap between discovery-stage research findings and potential clinical utility, accelerating programs towards their next objectives and milestones. Clinical stage services are focused on biomarker validation laboratory testing and CDx development on multiple platforms, including flow cytometry, multiplexed IHC, proteomics and PCR.
Our CRO relationship model allows for transparent sharing of information, coordinated decision-making and a high level of flexibility. We approach each project uniquely as a team-oriented research effort. We host frequent discussions with our Sponsors to determine ultimate study objectives, adapt to new information as it is generated, and provide insight wherever possible.